Hôpital Foch

Suresnes, Hauts-de-seine 92151

1 studies enrolling now · 2 studies all time

What they study most

Metastatic Castrate Resistant Prostate Cancer (mCRPC), Urothelial Cancer

Studies at this site

• Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy — Recruiting now
• A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1). — Running, not enrolling